Pharmacoepidemiology and Drug Safety : Impact Factor & More
eISSN: 1099-1557pISSN: 1053-8569
Share this on:
Key Metrics
CiteScore 
4
Impact Factor
< 5
SJR
Q2Epidemiology
SNIP
1.03
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Pharmacoepidemiology and Drug Safety
Pharmacoepidemiology and Drug Safety Journal Specifications
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1992 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Pharmacoepidemiology and Drug Safety ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Pharmacoepidemiology and Drug Safety
Use Patterns of Novel Janus Kinase Inhibitors After the First Safety Alerts: A Nationwide Register-Based Time Series Analysis.
- 1 Jun 2026
- Pharmacoepidemiology and drug safety
A Feasibility Assessment of the FDA Adverse Event Reporting System for the Detection of Cannabis-Related Safety Signals.
- 1 Jun 2026
- Pharmacoepidemiology and drug safety
Resumption of Antiplatelet Therapy After Burr-Hole Surgery and Recurrence in Patients With Chronic Subdural Hematoma: A Target Trial Emulation.
- 1 Jun 2026
- Pharmacoepidemiology and drug safety
Trajectories of Treatment Disruption for Chronic Outpatient Medications for U.S. Veterans During Drug Shortages.
- 1 Jun 2026
- Pharmacoepidemiology and drug safety
The Longer-Term Impact of Biosimilar Switching Policies in Patients With Inflammatory Bowel Disease in British Columbia, Canada: A Retrospective, Population-Based Study.
- 1 Jun 2026
- Pharmacoepidemiology and drug safety
Atypical Shoulder Pain and Dysfunction After Vaccinations Reported to the Vaccine Adverse Event Reporting System (VAERS) January 1, 2018, Through October 31, 2022.
- 1 Jun 2026
- Pharmacoepidemiology and drug safety
Use Patterns of Novel Janus Kinase Inhibitors After the First Safety Alerts: A Nationwide Register-Based Time Series Analysis.
- 1 Jun 2026
- Pharmacoepidemiology and drug safety
A Feasibility Assessment of the FDA Adverse Event Reporting System for the Detection of Cannabis-Related Safety Signals.
- 1 Jun 2026
- Pharmacoepidemiology and drug safety
Resumption of Antiplatelet Therapy After Burr-Hole Surgery and Recurrence in Patients With Chronic Subdural Hematoma: A Target Trial Emulation.
- 1 Jun 2026
- Pharmacoepidemiology and drug safety
Trajectories of Treatment Disruption for Chronic Outpatient Medications for U.S. Veterans During Drug Shortages.
- 1 Jun 2026
- Pharmacoepidemiology and drug safety
The Longer-Term Impact of Biosimilar Switching Policies in Patients With Inflammatory Bowel Disease in British Columbia, Canada: A Retrospective, Population-Based Study.
- 1 Jun 2026
- Pharmacoepidemiology and drug safety
Atypical Shoulder Pain and Dysfunction After Vaccinations Reported to the Vaccine Adverse Event Reporting System (VAERS) January 1, 2018, Through October 31, 2022.
- 1 Jun 2026
- Pharmacoepidemiology and drug safety
FAQs on Pharmacoepidemiology and Drug Safety
How long has Pharmacoepidemiology and Drug Safety been actively publishing? 
What is the publishing frequency of Pharmacoepidemiology and Drug Safety?
How many articles did Pharmacoepidemiology and Drug Safety publish last year?
What is the eISSN & pISSN for Pharmacoepidemiology and Drug Safety?
What is Citescore for Pharmacoepidemiology and Drug Safety?
What is SNIP score for Pharmacoepidemiology and Drug Safety?
What is the SJR for Pharmacoepidemiology and Drug Safety?
Who is the publisher of Pharmacoepidemiology and Drug Safety?
